When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Aspirin-exacerbated respiratory disease - Wikipedia

   en.wikipedia.org/wiki/Aspirin-exacerbated...

   Aspirin-exacerbated respiratory disease (AERD), also called NSAID-exacerbated respiratory disease (N-ERD) or historically aspirin-induced asthma and Samter's Triad, is a long-term disease defined by three simultaneous symptoms: asthma, chronic rhinosinusitis with nasal polyps, and intolerance of aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs).

3. Anti-asthmatic agent - Wikipedia

   en.wikipedia.org/wiki/Anti-asthmatic_agent

   Step 4: Daily symptoms, or waking with asthma once a week or more, and low lung function . Medium dose inhaled corticosteroids and formoterol maintenance therapy; Short-course oral corticosteroids when required in severely uncontrolled asthma; Step 5: Further worsening of symptoms and increased occurrence of exacerbations

4. Lisinopril - Wikipedia

   en.wikipedia.org/wiki/Lisinopril

   Lisinopril leaves the body completely unchanged in the urine. [1] [16] The half-life of lisinopril is 12 hours, and is increased in people with kidney problems. [1] [16] While the plasma half-life of lisinopril has been estimated between 12 and 13 hours, the elimination half-life is much longer, at around 30 hours. [18]

5. These are the signs we often miss in children with asthma and ...

   www.aol.com/news/signs-often-miss-children...

   Research shows asthma and depression are untreated or under-treated in children. Experts share signs of both in kids and share treatment options. These are the signs we often miss in children with ...

6. AOL Mail

   mail.aol.com

   Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!

7. Asthma - Wikipedia

   en.wikipedia.org/wiki/Asthma

   Asthma phenotyping and endotyping has emerged as a novel approach to asthma classification inspired by precision medicine which separates the clinical presentations of asthma, or asthma phenotypes, from their underlying causes, or asthma endotypes. The best-supported endotypic distinction is the type 2-high/type 2-low distinction.